Clearview Cancer Center

Quick Links:

Clearview News Wire

Copyright © 2007 Reuters Limited. All rights reserved. Republication or redistribution of Reuters content, including by framing or similar means, is expressly prohibited without the prior written consent of Reuters. Reuters shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon. Reuters and the Reuters sphere logo are registered trademarks and trademarks of the Reuters group of companies around the world.



Preventative mastectomy on the rise in the US

Last Updated: 2009-03-04 15:27:02 -0400 (Reuters Health)

March 5, 2009

NEW YORK (Reuters Health) - A growing proportion of American women with relatively benign form of cancer in one breast are choosing to have the other breast removed, researchers have found.

Ductal carcinoma in situ is a non-invasive form of breast cancer, and is very curable with surgery -- either a lumpectomy or mastectomy.

As lead investigator Dr. Todd M. Tuttle told Reuters Health, "Our findings indicate that women with noninvasive breast cancer are increasingly choosing to undergo double mastectomy. Importantly, removal of the opposite normal breast will not improve the survival rates for these patients, who have an excellent prognosis."

Tuttle and colleagues at the University of Minnesota Medical School, Minneapolis examined data on more than 51,000 women diagnosed with ductal carcinoma in situ in one breast from 1998 to 2005.

The rate of removal of the other, normal breast was 4.1 percent for all surgically treated patients and 13.5 percent for those who had a mastectomy, the team reports in the Journal of Clinical Oncology.

Among all the women treated surgically -- including those who underwent breast-conserving lumpectomy surgery -- the rate of preventative mastectomy of the other breast more than doubled from 2.1 percent in 1998 to 5.2 percent in 2005.

Excluding those who had breast-conserving surgery, the rate almost tripled from 6.4 percent to 18.4 percent.

In an accompanying editorial, Dr. Abram Recht of Harvard Medical School, Boston observes that the effect of this so-called contralateral prophylactic mastectomy is not completely clear.

"Regardless of any survival benefit," he writes, "some patients may feel contralateral prophylactic mastectomy will give them greater peace of mind."

SOURCE: Journal of Clinical Oncology, online February 17, 2009.

Other Articles:

June 11, 2013
Vegetable fats tied to less prostate cancer spread
June 5, 2013
U.S. Representative McCarthy diagnosed with lung cancer
June 4, 2013
Longer tamoxifen use cuts breast cancer recurrence
May 15, 2013
Actress has double mastectomy to elude breast cancer
May 15, 2013
FDA strengthens warnings on tanning beds
April 30, 2013
Supplements don't help with prostate cancer: study
April 25, 2013
New York City aims to ban cigarette sales under 21s
April 4, 2013
Smokers have worse colon cancer prognosis
April 3, 2013
Counsel women with likely BRCA family history
March 28, 2013
Soy tied to better lung cancer survival among women.
March 25, 2013
Help with end-of-life talks
March 22, 2013
Immune-system therapy shows promise in adults with leukemia
March 21, 2013
Umbrellas may shield you from more than rain: study
View All Cancer News